In the fast-moving field of obesity management, this practical, in-depth and comprehensive conference is a must attend. This unique day has been crafted to benefit all HCPs providing clinical management support and guidance to people living with obesity.
Take one day out to join us in Leeds to hear well-balanced, informative presentations from a wide selection of knowledgeable speakers. Partake in valuable, cross-discipline discussions and debates, plus learn from appropriate and timely industry partners in the dedicated networking breaks.
Sponsored by: 
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting.
Novo Nordisk has had no influence over the meeting agenda or arrangements.
5 hours Continuing Professional Development and networking: what you will learn
During the afternoon, this meeting will be split into 2 workstreams to ensure maximum learning.
Why should you attend?
With thanks to our sponsor
Are you from industry or a commercial company and interested in attending this face-to-face conference?
| 9:00 |
Registration, refreshments and networking opportunities
|
| 9:30 |
Chair’s opening remarks and introductions
Professor Rob Andrews, Associate Professor of Diabetes and Endocrinology, University of Exeter Medical School and Irena Cruickshank, Weight Management Nurse Specialist, Somerset NHS Foundation Trust
|
| National developments | |
| 9:40 |
Exploring new guidance and developments: implications for the obesity pathway
|
| 10:05 |
Questions and answers with your speaker
|
| Localised approaches | |
| 10:10 |
Best practice approaches to rolling out weight-loss drugs across Integrated Care Boards (ICBs). In this dedicated showcase, you will hear from two ICBs about their approach to the roll out including:
Gloucestershire ICB Perspective: Corinne Robinson, Senior Program Manager, Gloucestershire Integrated Care Board. Wiltshire Council Perspective: Katie Davies, Public Health Principal - Health Improvement, Wiltshire Council
|
| 11:00 |
Questions and answers with your speakers
|
| 11:10 |
Sponsored presentation opportunity
If you are an obesity management provider and would like to be part of this day, and present to this audience, please contact vanessa.pearce@sbk-healthcare.co.uk for further information.
|
| 11:20 |
Networking break
|
| 11:40 |
Interactive discussion: How best to support patients who are not eligible for weight-loss medications
|
| MDT approaches | |
| 12:10 |
Understanding the impact of obesity on cardiology: learnings from a combined clinic
Dr Mimi Chen, Specialist Consultant in Diabetes, St George's University Hospitals NHS Foundation Trust and Endocrinology and Dr Rajay Narain, Consultant Cardiologist, St George's University Hospitals NHS Foundation Trust
|
| 12:45 |
Questions and answers with your speakers
|
| 12:55 |
Networking lunch
|
|
You will have the opportunity to choose your workstream for the next session based your experience in weight-management.
|
|
| 1:55 |
Genetic obesity
|
| Workstream 1a |
Identifying and referring appropriate candidates for genetic testing
|
| Workstream 1b |
Genetic test results: how to manage and what you can offer patients
|
| 2:25 |
Weight-loss medication
|
| Workstream 2a |
Suitability and practicalities of weight-loss
Irena Cruickshank, Weight Management Nurse Specialist, Somerset NHS Foundation Trust
|
| Workstream 2b |
GLP-1 use in complex patient groups
Professor Rob Andrews, Associate Professor of Diabetes and Endocrinology, University of Exeter Medical School
|
| 2:55 |
Networking break
|
| Lifestyle changes | |
| 3:15 |
How to incorporate physical activity into weight management and understanding why it is important
Dr Matt Cocks, Reader in Exercise Physiology, Liverpool John Moores University
|
| 3:40 |
Questions and answers with your speakers
|
| Surgical interventions | |
| 3:50 |
Debate: We should only be offering one bariatric operation on the NHS
|
| 4:30 |
Closing remarks and conference summary
|
| 4:40 |
Close of conference
|
Meet the Obesity Management Advisory Board
Developed with the expertise of renowned leaders in the field, Prof Rob Andrews, Prof Sadaf Farooqi and Irena Cruikshank. This Obesity Management Advisory Board has created a groundbreaking event that offers cutting-edge insights and the latest clinical approaches to obesity management.
Rob Andrews is an associate Professor at the University of Exeter, an Honorary Consultant Physician at Musgrove Park Hospital Taunton.
At the University he leads a group that researches the role that exercise, and diet can play in the prevention and management of diabetes and obesity.
In Taunton, he leads the diabetes and obesity Research team. Until last year he was the medical lead for a large multidisciplinary weight management service. This is a holistic service offering specialised dietary and exercise programs, drug therapy and bariatric surgery as well as running clinics for people with eating disorders and complications post surgery. In recognition of this service, Taunton is designated an International Centre of Excellence for Bariatric Surgery.
Sadaf Farooqi is a Wellcome Principal Research Fellow and Professor of Metabolism and Medicine at the University of Cambridge, UK. She is an internationally leading Clinician Scientist who has made seminal contributions to understanding the genetic and physiological mechanisms that underlie obesity and its complications. The work of Sadaf Farooqi and her colleagues has fundamentally altered the understanding of how body weight is regulated. With colleagues, she discovered and characterised the first genetic disorders that cause severe childhood obesity and established that the principal driver of obesity in these conditions was a failure of the control of appetite. Her work is often cited as an exemplar of how the translation of research into the mechanisms of disease can lead to patient benefit. She has received a number of awards including the 2024 Outstanding Clinical Investigator Award from the Endocrine Society. In 2021, she was elected as a Fellow of the Royal Society in recognition of her exceptional contribution to science.
Irena is WM Nurse Specialist and Independent Prescriber at Musgrove Park Hospital, Somerset NHS FT. She initiates and follows up patients on injectable weight loss medications and has established clinics for genetic testing for Obesity.
Irena is involved in research projects to improve service delivery, using real world data from clinical practice.
She sat on NICE MTAC as a specialist committee member for early value assessment: digital technologies for providing specialist weight-management service. She is a member of the National Obesity Database Steering Group.
Irena has extensive nursing career in variety of acute clinical settings. She has made successful contribution to clinical research leading on COVID and diabetes trials and was a lead research nurse on STEP 1 trial, which aimed to assess the effect and safety of Semaglutide 2.4 mg once weekly in subjects with overweight or obesity. Despite being the smallest site in UK, their team had one of the best retention rates in the country and Irena was asked to share their success on international level.
Expert speaker line-up
Rob Andrews is an associate Professor at the University of Exeter, an Honorary Consultant Physician at Musgrove Park Hospital Taunton.
At the University he leads a group that researches the role that exercise, and diet can play in the prevention and management of diabetes and obesity.
In Taunton, he leads the diabetes and obesity Research team. Until last year he was the medical lead for a large multidisciplinary weight management service. This is a holistic service offering specialised dietary and exercise programs, drug therapy and bariatric surgery as well as running clinics for people with eating disorders and complications post surgery. In recognition of this service, Taunton is designated an International Centre of Excellence for Bariatric Surgery.
Irena is WM Nurse Specialist and Independent Prescriber at Musgrove Park Hospital, Somerset NHS FT. She initiates and follows up patients on injectable weight loss medications and has established clinics for genetic testing for Obesity.
Irena is involved in research projects to improve service delivery, using real world data from clinical practice.
She sat on NICE MTAC as a specialist committee member for early value assessment: digital technologies for providing specialist weight-management service. She is a member of the National Obesity Database Steering Group.
Irena has extensive nursing career in variety of acute clinical settings. She has made successful contribution to clinical research leading on COVID and diabetes trials and was a lead research nurse on STEP 1 trial, which aimed to assess the effect and safety of Semaglutide 2.4 mg once weekly in subjects with overweight or obesity. Despite being the smallest site in UK, their team had one of the best retention rates in the country and Irena was asked to share their success on international level.
Dr Chen is a specialist consultant in Diabetes and Endocrinology with a particular interest in weight loss and weight management medications. Specialties Include:
- Type 1 & 2 Diabetes
- Endocrinology
- Bariatric Medicine
- Diabetes Technology
- Closed Loop Systems
- Diabetes Pumps
- Lipid disorders
- Weight Management
Dr Narain is a Hon. Consultant Cardiologist at St. George's University Hospital, London. He is the Founding Director of Global Health Alliance, UK. He has set up U.K’s First Cardio-Metabolic Clinic at St Georges Hospital in London. Dr Narain is a Council Member for Myocardial & Pericardial Diseases and Stroke at the European Society of Cardiology. He is the Director of UK Cardiovascular & Diabetes Innovation Network.( UKCDIN). He is Hon Health Advisor to Govt of Ireland & Ukraine & several government & private institutions in Asia & Indian Sub-Continent.
Dr Matt Cocks is a Reader in Exercise Physiology at Liverpool John Moores University. His research focuses on supporting people with long-term conditions to become more physically active. In particular, he is interested in how wearable and mobile health (mHealth) technologies can be used to personalise home-based exercise interventions and improve adherence.
Matt leads the MOTIVATE projects, which use mHealth solutions to deliver tailored exercise programmes for individuals living with, or at risk of developing, long-term conditions. These include type 2 diabetes, cardiovascular disease (including cardiac rehabilitation), cancer, weight management in both adults and young people, and rheumatoid arthritis.
Call for Speakers
A one day conference dedicated to learning and networking
Venue details
Terms and Conditions
Past attendee feedback
"Very informative day which looked at and considered the wider holistic picture of patients living with obesity. Inspiring to be around many like minded individuals to tackle obesity stigma"
Worcestershire Acute Hospitals NHS Trust, Obesity Management National Networking Forum, November 2024
"I would highly recommend, well organised, good venue"
Frimley Health NHS Foundation Trust, Obesity Management National Networking Forum, November 2024
"Excellent day out, easy to access venue, content was very useful to inspire changes in my speciality"
University Hospitals of Leicester NHS Trust, Obesity Management National Networking Forum, November 2024
"Very informative and inspiring. great to meet a variety of professionals involved in obesity care"
Manor Surgery, Oxford, Obesity Management National Networking Forum, November 2024
"Engaging content throughout the day. Excellent knowledge and experience demonstrated by all presenters"
The Bariatric Group, Obesity Management National Networking Forum, November 2024
"A great day with lots of variety and enhanced my knowledge"
Betsi Cadwaladr University Health Board, Obesity Management National Networking Forum, November 2024
"Great to hear the thoughts of attendees across the board and share ways of addressing obesity."
Futureheads Newcastle, Obesity Management National Networking Forum, November 2024
With thanks to our sponsor
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases.
Novo Nordisk has provided sponsorship to SBK to cover the cost of stand space for this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements.
Why sponsor?
Interested in having your own event, managed by us?
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.